电子邮件 | san***@***.com | 获取Email |
---|
电子邮件 | san***@***.com | 获取Email |
---|
PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services. As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues. Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing. The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers. PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally. Why not get in touch to see how we can help you with your biosafety testing strategy?
公司 | PathoQuest |
---|---|
职位 | Head of Bioinformatics |
地点 | Canada |
http://www.linkedin.com/in/sandrine-moreira-rousseau-42334610 | |
部门 | master_engineering_technical |
头衔 | Head of Bioinformatics |
PathoQuest Head of Bioinformatics
2023-03-01 -
Université de Montréal Associate Professor
2019-01-01 -
Clinical Genomic and Bioinformatic laboratory lead
2017-01-01 -
Columbia University Postdoc in Bioinformatics
2017-01-01 - 2017-01-01
Université de Montréal Auxiliaire d'enseignement
2012-01-01 - 2014-01-01
Sandrine Rousseau 在 PathoQuest 担任 Head of Bioinformatics
Sandrine Rousseau 在 PathoQuest 的职位是 Head of Bioinformatics
Sandrine Rousseau 的电子邮件地址是 san***@***.com
Sandrine Rousseau 的电话号码是 -
Sandrine Rousseau 的公司电话号码是 +331****
Sandrine Rousseau 在 research 工作。
Sandrine Rousseau 的一些同事包括Matt Chancler、Colette Cote、Chrystelle Stirnemann、Yoann LecatTristan Poisson、。
Sandrine Rousseau联系方式: 电子邮件地址:san***@***.com 电话号码:-
Sandrine Rousseau 的个人领英是:http://www.linkedin.com/in/sandrine-moreira-rousseau-42334610
Sandrine Rousseau 的办公地点:11 rue Watt, Paris, Île-de-France, FR, 75013
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd